Real-time enrollment status for this spinal muscular atrophy (sma) clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:09 PM UTC
| NCT Number | NCT07287982 |
| Recruiting Status | Recruiting |
| Condition | Spinal Muscular Atrophy (SMA) |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 16 sites in the US |
| Sponsor | argenx |
| Last Updated on CT.gov | October 8, 2026 (1 week ago) |
As of October 21, 2026: Clinical trial NCT07287982 is currently recruiting participants. This phase2 study for spinal muscular atrophy (sma) is actively seeking new participants at 16 locations across the United States. The study is sponsored by argenx. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07287982 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07287982 was last updated 1 week ago (October 8, 2026). HelloStudys verifies this status automatically.